[Skip to Content]
Dementia and Cognitive Impairment

Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease

JAMA Neurology
Published Online: November 25, 2019 Audio Author Interview 17 min 18 sec
<title>Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease</title>
Backward 15 Play Pause Forward 15
1x
0:00 / 0:00
Download MP3

Interview with John Sims, author of Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials

Subscribe

Subscribe on your favorite podcast source to receive future episodes of this podcast.
Learn more about this JAMA Network podcast here

Related Articles

  1. Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

See More About

Dementia and Cognitive Impairment Neurology
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue